Loading

Welcome to ProBioGen

Providing Intelligent Biopharmaceutical Solutions

LATEST NEWS

Anti-Ebola MVA Vaccine Produced on ProBioGen’s Avian AGE1.CR® Cell Line Platform in Clinical Trials

20 years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion

UPCOMING EVENTS

07.09.2015 - 08.09.2015

Frankfurt, Germany

02.11.2015 - 05.11.2015

Munich, Germany